Latest news and press releases about NeuroOne Medical Technologies Corporation (NMTC): earnings reports, analyst upgrades/downgrades, product launches, partnerships and regulatory filings. Stay updated on every market-moving event.
NeuroOne Medical Technologies Corporation functions as a specialized medical technology enterprise. Its core mission involves the invention and market deployment of sophisticated thin-film electrode systems.
Price
| Price | $1.41 |
| Market Cap | $12M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 3.38 |
| EV / EBITDA | -1.84 |
| Dividend Yield | 0.00% |
Profitability
| Return on Equity | -126.45% |
| Return on Invested Capital | -183.45% |
| Return on Assets | -115.57% |
| Gross Margin | 55.67% |
| Operating Margin | -76.05% |
| Net Margin | -71.51% |
Related companies: ATHE · BDMD · CTSO · ECOR · HYPD · MYO · RBOT
Explore sector: Healthcare · Medical - Devices
More sections of NMTC: Overview · Financials · Valuation · Statistics · Estimates · Technical · Ownership · Events
Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks